Trial intelligence / Profile preview

AC meningococcal conjugate + Hib conjugate vaccine booster in toddlers

CTR20191760Phase 3Completed

Sponsor
Zhifei Biological
Start
Sep 2019
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of meningococcal groups a and c and haemophilus b conjugate vaccine in meningococcal disease, meningococcal group C disease, Haemophilus influenzae type b disease (Hib), sponsored by Zhifei Biological. Started Sep 2019; status: completed.

02

Drugs

meningococcal groups a and c and haemophilus b conjugate vaccine
03

Conditions

meningococcal diseasemeningococcal group C diseaseHaemophilus influenzae type b disease (Hib)

Beyond the preview

Go deeper on CTR20191760.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20191760.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call